ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

This study is currently recruiting participants.
Study NCT00575016.   Last updated on November 14, 2008.   Information provided by Allergan
Please refer to this study by its ClinicalTrials.gov identifier: NCT00575016


Contacts
Contact: Allergan Inc     clinicaltrials@allergan.com    

Locations
Serbia
Recruiting
      Belgrade, Serbia

Sponsors and Collaborators
Allergan

Investigators
Study Director:     Medical Director     Allergan    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers